Antimicrobial Susceptibility Pattern of Staphylococcus aureus Strains Isolated from Hospitalized Patients in Tehran, Iran Staphylococcus aureus susceptibility pattern
Iranian Journal of Pharmaceutical Sciences,
Vol. 6 Núm. 2 (2010),
1 April 2010
,
Página 125-132
https://doi.org/10.22037/ijps.v6.41259
Resumen
Staphylococcus aureus is a major bacterial pathogen that causes different community- and hospital-acquired infections. Over time, strains of S. aureus have become resistant to different antibiotics including penicillinase-resistant penicillins. Having data on the local antimicrobial susceptibility pattern of this pathogen is necessary for selection of appropriate antibiotics for empirical treatment of infections
due to it. To determine the antimicrobial susceptibility pattern of Staphylococcus aureus strains isolated from hospitalized patients in Tehran, Iran, In a prospective cross-sectional study performed at Imam Khomeini Hospital, samples were collected from hospitalized patients and were cultured. All positive cultures which yielded S. aureus underwent antimicrobial susceptibility testing using the Kirby-Bauer
disk diffusion method on Mueller-Hinton agar. The results were interpreted after 24 hours of incubation at 37 °C. A total of 160 clinical isolates of S. aureus were collected. Most isolates were obtained from blood (29%). The overall susceptibility of isolated S. aureus strains to antimicrobial agents was 100% for vancomycin, 49.4% for amikacin, 43.8% for gentamicin, 36.8% for co-trimoxazole and tetracycline, 36.3%
for cefazolin, 30.6% for cephalexin, 24.4% for oxacillin, 23.8% for erythromycin, and 3.1% for penicillin. Other than vancomycin, none of the tested antibiotics are appropriate for empirical treatment of serious S .aureus infections in our area.
- Antimicrobials
- Resistance
- Staphylococcus aureus
- Susceptibility
Cómo citar
Citas
[2] Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
[3] Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N.Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
[4] Clinical and Laboratory Standards Institute.Performance standard for antimicrobial susceptibility testing. Document M100–S19. Vol 29, No 3. Wayne, PA: CLSI.
[5] Mamishi S, Pourakbari B, Ashtiani MH, and Hashemi FB. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children’s Medical Center, Tehran, Iran, 1996-2000. Int J Antimicrob Agents 2005; 26: 373-9.
[6] Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, Sader HS. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997. Clin Infect Dis 1999; 29: 595-607.
[7] Schmitz FJ, Lindenlauf E, Hofmann B, Fluit AC, Verhoef J, Heinz HP, Jones ME. The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 1998; 42: 489-95.
[8] Haghi-Ashteiani M, Sadeghifard N, Abedini M, Soroush S, Taheri-Kalani M. Etiology and antibacterial resistance of bacterial urinary tract infections in Children’s Medical Center, Tehran, Iran. Acta Med Iran 2007; 45: 153-7.
[9] Alborzi A, Pourabbas Ba, Salehi H, Pourabbas Bh, Oboodi B, Panjehshahin MR. Prevalence and pattern of antibiotic sensitivity of methicillinsensitive and methicillin-resistant Staphylococcus aureus in Shiraz-Iran. Iranian J Med Sci 2000; 25:1-8.
[10] Farzana K, Hameed A. Resistance pattern of clinical isolates of Staphylococcus aureus against five groups of antibiotics. J Res Sci 2006; 17: 19-26.
[11] Goff DA, Dowzicky MJ. Prevalence and regional variation in meticillin-resistant Staphylococcus aureus (MRSA) in the USA and comparative in vitro activity of tigecycline, a glycylcycline antimicrobial. J Med Microbiol 2007; 56: 1189-93.
[12] Fridkin SK, Hill HA, Volkov NV, Edwards JR,Lawton RM, Gaynes RP, McGowan JE. Temporal changes in prevalence of antimicrobial resistance in 23 U.S. hospitals. Emerg Infect Dis 2002; 8:697-701.
[13] Voss A, Milatovic D, Wallrauch-Schwartz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Micr Infect Dis 1994; 13: 50-5.
[14] Ikeagwu IJ, Amadi ES, Iroha IR. Antibiotic sensitivity pattern of Staphylococcus aureus in Abakaliki, Nigeria. Pak J Med Sci 2008; 24: 231-5.
[15] Martin JN, Rose DA, Hadley WK, Perdreau-Remington F, Lam PK, Gerberding JL.Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis 1999; 180: 1809-18.
[16] Bishara J, Pitlik S, Samra Z, Levy I, Paul M, Leibovici L. Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997. Emerg Infect Dis 2003; 9: 1168-9.
[17] Kalantar E, Mosaei M, Ekrami A, Pedram M. Isolation and antimicrobial susceptibility of bacteria from external ear canal of cancer patients at Shafa Cancer Hospital-Ahwaz. J Cancer Res Ther 2006; 2: 17-9.
[18] Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagn Microbiol Infect Dis 2008; 62: 67-80.
[19] Fasching CE, Tenover FC, Slama TG, Fisher LM, Sreedharan S, Oram M. gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. J Infect Dis 1991; 164: 976-9.
[20] Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 2003; 15: 36: 429-39.
[21] Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-6.
[22] Center for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States. Morb Mortal Wkly Rep 2002; 51:565-7.
[23] Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-7.
[24] Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008; 46: 668-74.
[25] Kalantari N, Taherikalani M, Parvaneh N, Mamishi S. Etiology and antimicrobial susceptibility of bacterial septic arthritis and osteomyelitis. Iranian J Publ Health 2007; 36: 27-32.
[26] Emaneini M, Aligholi M, Hashemi FB, Jabalameli F, Shasavan S, Dabiri H, Jonaidi N, Dahi K.Isolation of vancomycin-resistant Staphylococcus aureus in a teaching hospital in Tehran. J Hosp Infect 2007; 66:92-3.
- Resumen ##plugins.themes.ojsPlusA.frontend.article.viewed##: 92 ##plugins.themes.ojsPlusA.frontend.article.times##
- IJPS_Volume 6_Issue 2_Pages 125-132 (English) ##plugins.themes.ojsPlusA.frontend.article.downloaded##: 25 ##plugins.themes.ojsPlusA.frontend.article.times##